Table of Content

1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17

2 Market Overview and Dynamics 20
2.1 Market Size and Forecast 20
2.1.1 Impact of COVID-19 on the Market 21
2.2 Major Growth Drivers 23
2.3 Market Restraints and Challenges 27
2.4 Emerging Opportunities and Market Trends 30
2.5 Porter’s Fiver Forces Analysis 34

3 Segmentation of Europe Market by Drug Class 38
3.1 Market Overview by Drug Class 38
3.2 Cephalosporin 40
3.3 Penicillin 42
3.4 Macrolides 43
3.5 Tetracycline 44
3.6 Quinolones 45
3.7 Sulfonamides 46
3.8 Aminoglycosides 47
3.9 Other Drug Classes 48

4 Segmentation of Europe Market by Action Mechanism 49
4.1 Market Overview by Action Mechanism 49
4.2 Cell Wall Synthesis Inhibitors 51
4.3 Mycolic Acid Inhibitors 52
4.4 RNA Synthesis Inhibitors 53
4.5 DNA Synthesis Inhibitors 54
4.6 Protein Synthesis Inhibitors 55
4.7 Other Mechanisms 56

5 Segmentation of Europe Market by Drug Origin 57
5.1 Market Overview by Drug Origin 57
5.2 Natural Antibiotics 59
5.3 Semi-synthetic Antibiotics 60
5.4 Synthetic Antibiotics 61

6 Segmentation of Europe Market by Activity Spectrum 62
6.1 Market Overview by Activity Spectrum 62
6.2 Broad-spectrum Antibiotics 64
6.3 Narrow-spectrum Antibiotics 65

7 Segmentation of Europe Market by Application 66
7.1 Market Overview by Application 66
7.2 Urinary Tract Infections (UTIS) 68
7.3 Dental Infections 69
7.3.1 Monotherapies for Dental Infections 70
7.3.2 Combined Therapies for Dental Infections 71
7.4 Respiratory Tract Infections (RTIS) 72
7.4.1 Upper Respiratory Tract Infections (URTI) 73
7.4.2 Lower Respiratory Tract Infections (LRTIs) 74
7.5 Other Applications 75

8 Segmentation of Europe Market by Drug Type 76
8.1 Market Overview by Drug Type 76
8.2 Brand Antibiotics 78
8.3 Generic Antibiotics 79

9 European Market 2019-2030 by Country 80
9.1 Overview of European Market 80
9.2 Germany 83
9.3 UK 85
9.4 France 88
9.5 Spain 90
9.6 Italy 92
9.7 Russia 94
9.8 Rest of European Market 96

10 Competitive Landscape 98
10.1 Overview of Key Vendors 98
10.2 New Product Launch, Partnership, Investment, and M&A 101
10.3 Company Profiles 102
Abbott Laboratories 102
Astellas Pharma 104
AstraZeneca Plc 105
Bayer AG 106
Bristol Myers Squibb Company 107
Cipla Inc. 108
Dr. Reddy’s Laboratories Ltd. 109
Eli Lilly and Company 110
F. Hoffmann-La Roche Ltd. 111
Gilead Sciences, Inc. 112
GlaxoSmithKline plc. 113
Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals) 114
Mayne Pharma Group Ltd. 115
MELINTA THERAPEUTICS, INC. 116
Merck KGaA 117
Novartis AG 118
Pfizer Inc. 119
Sanofi 120
Sun Pharmaceutical Industries Ltd. 121

11 Investing in Europe Market: Risk Assessment and Management 122
11.1 Risk Evaluation of Europe Market 122
11.2 Critical Success Factors (CSFs) 125
Related Reports and Products 128



List of Figures


Figure 1. Research Method Flow Chart 11
Figure 2. Breakdown of Primary Research 13
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 15
Figure 4. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 17
Figure 5. Europe Oral Antibiotics Market, 2019-2030, $ mn 20
Figure 6. Impact of COVID-19 on Business 21
Figure 7. Primary Drivers and Impact Factors of Europe Oral Antibiotics Market 23
Figure 8. GDP per capita in the World, 1960-2018, $ thousand 26
Figure 9. Forecast of Middle-class Population by Region, 2015-2030, million 26
Figure 10. Primary Restraints and Impact Factors of Europe Oral Antibiotics Market 27
Figure 11. Investment Opportunity Analysis 31
Figure 12. Porter’s Fiver Forces Analysis of Europe Oral Antibiotics Market 34
Figure 13. Breakdown of Europe Oral Antibiotics Market by Drug Class, 2019-2030, % of Revenue 39
Figure 14. Europe Addressable Market Cap in 2020-2030 by Drug Class, Value ($ mn) and Share (%) 39
Figure 15. Europe Oral Antibiotics Market: Cephalosporin, 2019-2030, $ mn 40
Figure 16. Europe Oral Antibiotics Market: Penicillin, 2019-2030, $ mn 42
Figure 17. Europe Oral Antibiotics Market: Macrolides, 2019-2030, $ mn 43
Figure 18. Europe Oral Antibiotics Market: Tetracycline, 2019-2030, $ mn 44
Figure 19. Europe Oral Antibiotics Market: Quinolones, 2019-2030, $ mn 45
Figure 20. Europe Oral Antibiotics Market: Sulfonamides, 2019-2030, $ mn 46
Figure 21. Europe Oral Antibiotics Market: Aminoglycosides, 2019-2030, $ mn 47
Figure 22. Europe Oral Antibiotics Market: Other Drug Classes, 2019-2030, $ mn 48
Figure 23. Breakdown of Europe Oral Antibiotics Market by Action Mechanism, 2019-2030, % of Sales Revenue 50
Figure 24. Europe Addressable Market Cap in 2020-2030 by Action Mechanism, Value ($ mn) and Share (%) 50
Figure 25. Europe Oral Antibiotics Market: Cell Wall Synthesis Inhibitors, 2019-2030, $ mn 51
Figure 26. Europe Oral Antibiotics Market: Mycolic Acid Inhibitors, 2019-2030, $ mn 52
Figure 27. Europe Oral Antibiotics Market: RNA Synthesis Inhibitors, 2019-2030, $ mn 53
Figure 28. Europe Oral Antibiotics Market: DNA Synthesis Inhibitors, 2019-2030, $ mn 54
Figure 29. Europe Oral Antibiotics Market: Protein Synthesis Inhibitors, 2019-2030, $ mn 55
Figure 30. Europe Oral Antibiotics Market: Other Mechanisms, 2019-2030, $ mn 56
Figure 31. Breakdown of Europe Oral Antibiotics Market by Drug Origin, 2019-2030, % of Sales Revenue 58
Figure 32. Europe Addressable Market Cap in 2020-2030 by Drug Origin, Value ($ mn) and Share (%) 58
Figure 33. Europe Oral Antibiotics Market: Natural Antibiotics, 2019-2030, $ mn 59
Figure 34. Europe Oral Antibiotics Market: Semi-synthetic Antibiotics, 2019-2030, $ mn 60
Figure 35. Europe Oral Antibiotics Market: Synthetic Antibiotics, 2019-2030, $ mn 61
Figure 36. Breakdown of Europe Oral Antibiotics Market by Activity Spectrum, 2019-2030, % of Revenue 63
Figure 37. Europe Addressable Market Cap in 2020-2030 by Activity Spectrum, Value ($ mn) and Share (%) 63
Figure 38. Europe Oral Antibiotics Market: Broad-spectrum Antibiotics, 2019-2030, $ mn 64
Figure 39. Europe Oral Antibiotics Market: Narrow-spectrum Antibiotics, 2019-2030, $ mn 65
Figure 40. Breakdown of Europe Oral Antibiotics Market by Application, 2019-2030, % of Revenue 67
Figure 41. Europe Addressable Market Cap in 2020-2030 by Application, Value ($ mn) and Share (%) 67
Figure 42. Europe Oral Antibiotics Market: Urinary Tract Infections (UTIS), 2019-2030, $ mn 68
Figure 43. Europe Oral Antibiotics Market: Dental Infections, 2019-2030, $ mn 69
Figure 44. Europe Oral Antibiotics Market: Monotherapies for Dental Infections, 2019-2030, $ mn 70
Figure 45. Europe Oral Antibiotics Market: Combined Therapies for Dental Infections, 2019-2030, $ mn 71
Figure 46. Europe Oral Antibiotics Market: Respiratory Tract Infections (RTIS), 2019-2030, $ mn 72
Figure 47. Europe Oral Antibiotics Market: Upper Respiratory Tract Infections (URTI), 2019-2030, $ mn 73
Figure 48. Europe Oral Antibiotics Market: Lower Respiratory Tract Infections (LRTIs), 2019-2030, $ mn 74
Figure 49. Europe Oral Antibiotics Market: Other Applications, 2019-2030, $ mn 75
Figure 50. Breakdown of Europe Oral Antibiotics Market by Drug Type, 2019-2030, % of Revenue 76
Figure 51. Europe Addressable Market Cap in 2020-2030 by Drug Type, Value ($ bn) and Share (%) 77
Figure 52. Europe Oral Antibiotics Market: Brand Antibiotics, 2019-2030, $ bn 78
Figure 53. Europe Oral Antibiotics Market: Generic Antibiotics, 2019-2030, $ bn 79
Figure 54. Breakdown of European Oral Antibiotics Market by Country, 2019 and 2030, % of Revenue 81
Figure 55. Contribution to Europe 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%) 82
Figure 56. Oral Antibiotics Market in Germany, 2019-2030, $ bn 83
Figure 57. Oral Antibiotics Market in UK, 2019-2030, $ bn 85
Figure 58. Oral Antibiotics Market in France, 2019-2030, $ bn 88
Figure 59. Oral Antibiotics Market in Spain, 2019-2030, $ bn 90
Figure 60. Oral Antibiotics Market in Italy, 2019-2030, $ bn 92
Figure 61. Oral Antibiotics Market in Russia, 2019-2030, $ bn 94
Figure 62. Oral Antibiotics Market in Rest of Europe, 2019-2030, $ bn 96
Figure 63. Growth Stage of Europe Oral Antibiotics Industry over the Forecast Period 98


List of Tables


Table 1. Snapshot of Europe Oral Antibiotics Market, 2019-2030 18
Table 2. Main Product Trends and Market Opportunities in Europe Oral Antibiotics Market 30
Table 3. Europe Oral Antibiotics Market by Drug Class, 2019-2030, $ mn 38
Table 4. Europe Oral Antibiotics Market: Cephalosporin by Molecule, 2019-2030, $ mn 41
Table 5. Europe Oral Antibiotics Market by Action Mechanism, 2019-2030, $ mn 49
Table 6. Europe Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn 57
Table 7. Europe Oral Antibiotics Market by Activity Spectrum, 2019-2030, $ mn 62
Table 8. Europe Oral Antibiotics Market by Application, 2019-2030, $ mn 66
Table 9. Europe Oral Antibiotics Market: Dental Infections by Type, 2019-2030, $ mn 69
Table 10. Europe Oral Antibiotics Market: Respiratory Tract Infections (RTIS) by Type, 2019-2030, $ mn 72
Table 11. Europe Oral Antibiotics Market by Drug Type, 2019-2030, $ bn 76
Table 12. Europe Oral Antibiotics Market by Country, 2019-2030, $ bn 82
Table 13. Germany Oral Antibiotics Market by Drug Class, 2019-2030, $ mn 84
Table 14. Germany Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn 84
Table 15. Germany Oral Antibiotics Market by Application, 2019-2030, $ mn 84
Table 16. UK Oral Antibiotics Market by Drug Class, 2019-2030, $ mn 87
Table 17. UK Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn 87
Table 18. UK Oral Antibiotics Market by Application, 2019-2030, $ mn 87
Table 19. France Oral Antibiotics Market by Drug Class, 2019-2030, $ mn 89
Table 20. France Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn 89
Table 21. France Oral Antibiotics Market by Application, 2019-2030, $ mn 89
Table 22. Spain Oral Antibiotics Market by Drug Class, 2019-2030, $ mn 91
Table 23. Spain Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn 91
Table 24. Spain Oral Antibiotics Market by Application, 2019-2030, $ mn 91
Table 25. Italy Oral Antibiotics Market by Drug Class, 2019-2030, $ mn 93
Table 26. Italy Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn 93
Table 27. Italy Oral Antibiotics Market by Application, 2019-2030, $ mn 93
Table 28. Russia Oral Antibiotics Market by Drug Class, 2019-2030, $ mn 95
Table 29. Russia Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn 95
Table 30. Russia Oral Antibiotics Market by Application, 2019-2030, $ mn 95
Table 31. Oral Antibiotics Market in Rest of Europe by Country, 2019-2030, $ bn 97
Table 32. Abbott Laboratories: Company Snapshot 102
Table 33. Abbott Laboratories: Business Segmentation 102
Table 34. Abbott Laboratories: Product Portfolio 103
Table 35. Abbott Laboratories: Revenue, 2016-2018, $ mn 103
Table 36. Abbott Laboratories: Recent Developments 103
Table 37. Risk Evaluation for Investing in Europe Market, 2019-2030 123
Table 38. Critical Success Factors and Key Takeaways 126